GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » Cyclically Adjusted Book per Share

Maccura Biotechnology Co (SZSE:300463) Cyclically Adjusted Book per Share : ¥6.35 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Maccura Biotechnology Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥10.583. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥6.35 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Maccura Biotechnology Co's average Cyclically Adjusted Book Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-16), Maccura Biotechnology Co's current stock price is ¥13.22. Maccura Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥6.35. Maccura Biotechnology Co's Cyclically Adjusted PB Ratio of today is 2.08.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Maccura Biotechnology Co was 3.34. The lowest was 1.78. And the median was 2.57.


Maccura Biotechnology Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Maccura Biotechnology Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co Cyclically Adjusted Book per Share Chart

Maccura Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 6.24

Maccura Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.57 5.75 6.03 6.24 6.35

Competitive Comparison of Maccura Biotechnology Co's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Maccura Biotechnology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maccura Biotechnology Co's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Maccura Biotechnology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Maccura Biotechnology Co's Cyclically Adjusted PB Ratio falls into.



Maccura Biotechnology Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Maccura Biotechnology Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.583/115.2271*115.2271
=10.583

Current CPI (Mar. 2024) = 115.2271.

Maccura Biotechnology Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 98.200 0.000
201409 0.000 98.900 0.000
201412 1.419 99.000 1.652
201503 1.426 99.900 1.645
201506 3.371 99.500 3.904
201509 3.473 100.500 3.982
201512 3.576 100.600 4.096
201603 3.699 102.200 4.170
201606 3.786 101.400 4.302
201609 3.921 102.400 4.412
201612 4.020 102.600 4.515
201703 4.190 103.200 4.678
201706 4.216 103.100 4.712
201709 4.388 104.100 4.857
201712 4.482 104.500 4.942
201803 4.427 105.300 4.844
201806 4.505 104.900 4.949
201809 4.653 106.600 5.030
201812 4.830 106.500 5.226
201903 5.054 107.700 5.407
201906 5.180 107.700 5.542
201909 5.388 109.800 5.654
201912 5.606 111.200 5.809
202003 5.701 112.300 5.850
202006 5.942 110.400 6.202
202009 6.406 111.700 6.608
202012 6.815 111.500 7.043
202103 7.214 112.662 7.378
202106 6.988 111.769 7.204
202109 7.420 112.215 7.619
202112 7.725 113.108 7.870
202203 9.891 114.335 9.968
202206 9.807 114.558 9.864
202209 10.098 115.339 10.088
202212 10.275 115.116 10.285
202303 10.452 115.116 10.462
202306 10.201 114.558 10.261
202309 10.341 115.339 10.331
202312 10.425 114.781 10.466
202403 10.583 115.227 10.583

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Maccura Biotechnology Co  (SZSE:300463) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Maccura Biotechnology Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=13.22/6.35
=2.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Maccura Biotechnology Co was 3.34. The lowest was 1.78. And the median was 2.57.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Maccura Biotechnology Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Maccura Biotechnology Co (SZSE:300463) Business Description

Traded in Other Exchanges
N/A
Address
Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Maccura Biotechnology Co (SZSE:300463) Headlines

No Headlines